Editorial

Published on 19 Sep 2023

Editorial: Exploring oncolytic virus-mediated changes in immune microenvironment and immune cells in solid tumors

in Vaccines and Molecular Therapeutics

Hongwei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1234957

1,396 views

Original Research

Published on 18 Sep 2023

Intranasally inoculated bacterium-like particles displaying porcine epidemic diarrhea virus S1 protein induced intestinal mucosal immune response in mice

in Vaccines and Molecular Therapeutics

Kai Su
Yawen Wang
Chen Yuan
Yanan Zhang
Yanrui Li
Tanqing Li
Qinye Song

Frontiers in Immunology

doi 10.3389/fimmu.2023.1269409

2,508 views
3 citations

Clinical Trial

Published on 18 Sep 2023

Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial

in Vaccines and Molecular Therapeutics

Jialei Hu
Yueyue Liu
Shuo Liu
Qun Shu
Xuenan Yang
Kai Chu
Yaping Qiao
Yaling Hu
Kaiqin Wang
Hongxing Pan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1241153

1,850 views
3 citations

Original Research

Published on 18 Sep 2023

Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways

in Vaccines and Molecular Therapeutics

Diego A. Díaz-Dinamarca
Michelle L. Salazar
Daniel F. Escobar
Byron N. Castillo
Bastián Valdebenito
Pablo Díaz
Augusto Manubens
Fabián Salazar
Mayarling F. Troncoso
Sergio Lavandero

Frontiers in Immunology

doi 10.3389/fimmu.2023.1186188

3,000 views
1 citation

Original Research

Published on 18 Sep 2023

A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis

in Vaccines and Molecular Therapeutics

Ana Alonso
Pedro José Alcolea
Jaime Larraga
María Paz Peris
Adriana Esteban
Alberto Cortés
Silvia Ruiz-García
Juan Antonio Castillo
Vicente Larraga

Frontiers in Immunology

doi 10.3389/fimmu.2023.1213193

3,056 views
1 citation

Correction

Published on 15 Sep 2023

Expression of concern on: Immunoreactivity of sera from low to moderate malaria-endemic areas against plasmodium vivax rPvs48/45 proteins produced in Escherichia coli and Chinese hamster ovary systems

in Vaccines and Molecular Therapeutics

Frontiers Editorial Office

Frontiers in Immunology

doi 10.3389/fimmu.2023.1292349

661 views

Correction

Published on 15 Sep 2023

Expression of concern on: A SARS–CoV-2 spike receptor binding motif peptide induces anti-spike antibodies in mice andIs recognized by COVID-19 patients

in Vaccines and Molecular Therapeutics

Frontiers Editorial Office

Frontiers in Immunology

doi 10.3389/fimmu.2023.1292353

652 views

Original Research

Published on 15 Sep 2023

Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responses

in Vaccines and Molecular Therapeutics

Marek Adam Harhala
Katarzyna Gembara
Izabela Rybicka
Zuzanna Maria Kaźmierczak
Paulina Miernikiewicz
Joanna Marta Majewska
Wiktoria Budziar
Anna Nasulewicz-Goldeman
Daniel C. Nelson
Barbara Owczarek

Frontiers in Immunology

doi 10.3389/fimmu.2023.1075774

2,075 views

Review

Published on 14 Sep 2023

Dendritic cell vaccine of gliomas: challenges from bench to bed

in Vaccines and Molecular Therapeutics

Ye Zheng
Xiaoyu Ma
Shouchang Feng
Hongtao Zhu
Xin Chen
Xingjiang Yu
Kai Shu
Suojun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1259562

3,509 views
3 citations

Original Research

Published on 14 Sep 2023

Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms

in Vaccines and Molecular Therapeutics

Weiming Wang
Khanghy Truong
Chaobaihui Ye
Suman Sharma
Huan He
Lihong Liu
Michael Wen
Anisha Misra
Paul Zhou
Jason T. Kimata

Frontiers in Immunology

doi 10.3389/fimmu.2023.1167965

2,647 views

Original Research

Published on 13 Sep 2023

Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo

in Vaccines and Molecular Therapeutics

Diahann T. S. L. Jansen
Monique T. A. de Beijer
Robbie J. Luijten
Kitty Kwappenberg
Anna-Sophia Wiekmeijer
Amy L. Kessler
Roel F. A. Pieterman
Rachid Bouzid
Willem-Jan Krebber
Robert A. de Man

Frontiers in Immunology

doi 10.3389/fimmu.2023.1163118

2,502 views
3 citations

Perspective

Published on 13 Sep 2023

The 1926 novel, “One, no one, one hundred thousand”, metaphorizes the potential danger when the immune system is exposed to a repetitive antigen stimulation

in Vaccines and Molecular Therapeutics

Francesca Ferrazzo
Sara Leto
Natalia Malara

Frontiers in Immunology

doi 10.3389/fimmu.2023.1254853

3,463 views

Correction

Published on 12 Sep 2023

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus

in Vaccines and Molecular Therapeutics

Mallory L. Myers
John R. Gallagher
De’Marcus D. Woolfork
Regan K. Stradtmann-Carvalho
Samantha Maldonado-Puga
Kevin W. Bock
Seyhan Boyoglu-Barnum
Hubza Syeda
Adrian Creanga
Derron A. Alves

Frontiers in Immunology

doi 10.3389/fimmu.2023.1283355

818 views

Systematic Review

Published on 12 Sep 2023

Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework

in Vaccines and Molecular Therapeutics

Xuan Wang
Katrin Haeussler
Anne Spellman
Leslie E. Phillips
Allison Ramiller
Mary T. Bausch-Jurken
Pawana Sharma
Anna Krivelyova
Sonam Vats
Nicolas Van de Velde

Frontiers in Immunology

doi 10.3389/fimmu.2023.1204831

8,246 views
22 citations

Review

Published on 11 Sep 2023

CCHFV vaccine development, current challenges, limitations, and future directions

in Vaccines and Molecular Therapeutics

Büşra Ahata
Günseli Bayram Akçapınar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1238882

6,845 views
11 citations

Original Research

Published on 11 Sep 2023

Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice

in Vaccines and Molecular Therapeutics

Dominik Pflumm
Alina Seidel
Fabrice Klein
Rüdiger Groß
Lea Krutzke
Stefan Kochanek
Joris Kroschel
Jan Münch
Katja Stifter
Reinhold Schirmbeck

Frontiers in Immunology

doi 10.3389/fimmu.2023.1231274

3,058 views
1 citation

Navigation group

Articles

Editorial: Exploring oncolytic virus-mediated changes in immune microenvironment and immune cells in solid tumors

Intranasally inoculated bacterium-like particles displaying porcine epidemic diarrhea virus S1 protein induced intestinal mucosal immune response in mice

Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial

Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways

A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis

Expression of concern on: Immunoreactivity of sera from low to moderate malaria-endemic areas against plasmodium vivax rPvs48/45 proteins produced in Escherichia coli and Chinese hamster ovary systems

Expression of concern on: A SARS–CoV-2 spike receptor binding motif peptide induces anti-spike antibodies in mice andIs recognized by COVID-19 patients

Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responses

Dendritic cell vaccine of gliomas: challenges from bench to bed

Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms

Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo

The 1926 novel, “One, no one, one hundred thousand”, metaphorizes the potential danger when the immune system is exposed to a repetitive antigen stimulation

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus

Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework

CCHFV vaccine development, current challenges, limitations, and future directions

Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice